Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving virus or bacteriophage
Patent
1995-01-09
1998-05-26
Zitomer, Stephanie W.
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving virus or bacteriophage
435 6, 435 912, 536 243, 536 2432, 536 245, 514 44, C12Q 170, C12Q 168, C07H 2104, C12P 1934
Patent
active
057562822
ABSTRACT:
Oligonucleotides are provided which are targeted to human papillomavirus E2 transactivator messenger RNA. Such oligonucleotides can be used for diagnostics and therapeutics as well as for research purposes.
REFERENCES:
patent: 4983728 (1991-01-01), Herzog et al.
Yang et al. PNAS 82:1030-1034, 1985.
Durst et al, PNAS 80: 3812-3815, 1983.
Agrawal and Sarin, "Antisense oligonucleotides: gene regulation and chemotherapy of AIDS", Adv. Drug Deliv. Rev. (1991) 6:251-270.
Amtmann, E. & Sauer, G., J. Virol. 4:59-66 (1982).
Androphy, E.J., Lowy, D.R. & Schiller, J.T., Nature 325, 70-73 (1987).
Baker, C.C. & Howley, P.M., EMBO J. 6:1027-1035 (1987).
Boshart, M., Gissmann, L., Ikenberg, H., Kleinheinz, A., Scheurlen, W. & zur Hausen, H., EMBO J. 3:1151-1157 (1984).
Chen, E. Y., Howley, P. M., Levinson, A. D., and Seeburg, P. H., "The primary structure and genetic organization of the bovine papillomavirus type 1 genome", Nature 299:529-534 (1982).
Chin, M.T., Hirochika, R., Hirochika, H., Broker, T.R. & Chow, L.T., J. Virol. 62:2994-3002 (1988).
Cole, S.T. and Danos, O., "Nucleotide Sequence and Comparative Analysis of the Human Papillomavirus Type 18 Genome", J. Mol. Biol. 193, 599-608 (1987).
Cole, S.T. and Streeck, R.E., "Genome Organization and Nucleotide Sequence of Human Papillomavirus Type 33, Which Is Associated with Cervical Cancer", J. Virol. 58, 991-995 (1986).
Cowsert, L. M., Lake, P., and Jenson, A. B., "Topographical and conformational Epitopes of Bovine Papillomavirus type 1 Defined by Monoclonal Antibodies", JNCI 79:1053-1057 (1987).
Dartmann et al., Virology 151, 124-130 (1986).
DiMaio, D., J. Virol. 57:475-480 (1986).
DiMaio, D. & Settleman, J., EMBO J. 7:1197-1204 (1988).
Durst, M., Gissmann, L., Ikenberg, H. & zur Hausen, H., Proc. Natl. Acad. Sci. USA 80:3812-3815 (1983).
Dvoretzky, I. Schober, R., and Lowy, D., "Focus Assay in Mouse Cells for Bovine Papillomavirus type 1", Virology 103:369-375 (1980).
Dahlberg, A. E., Digman, C. W. and Peacock, A. C., J. Mol. Biol. 41:39 (1969).
Engel, L.W., Heilman, C.A. & Howley, P.M., J. Virol. 47:516-528 (1983).
Frost, E. and Williams, J., "Mapping Temperature-Sensitive and host-range mutation of Adenovirus type 5 by Marker Rescue", Virology 91:39-50 (1978).
Fuchs et al., "Epidermodysplasia Verruciformis-Associated Human Papillomavirus 8: Genomic Sequence and Comparative Analysis", J. Virol. 58, 626-634 (1986).
Gennaro, Alfonso, Ed., Remington's Pharmaceutical Sciences, 18th Edition 1990. Mack Publishing Co., Easton, PA.
Gissmann, L., Wolnik, L., Ikenberg, H., Koldovsky, U., Schnurch, H.G. & zur Hausen, H., Proc. Natl. Acad. Sci. USA 80:560-563 (1983).
Gius, D., Grossman, S., Bedell, M.A. & Laimins, L.A., J. Virol. 62:665-672 (1988).
Goldsborough et al. "Nucleotide Sequence of Human Papillomavirus Type 31: A Cervical Neoplasia-Associated Virus", Virology 171, 306-311 (1989).
Graham, F. L. and van der Eb, A. J., "A New Technique for the Assay of Infectivity of Human Adenovirus 5 DNA", Virology 52:456-461 (1973).
Groff, D.E. & Lancaster, W.D., Virology 150:221-230 (1986).
Groman, C.M., Moffat, L.F., and Howard, B.H., Mol. Cell. Biol. 2:1044-1051 (1982).
Heilman, C.A., Engel, L., Lowy, D.R. & Howley, P.M., Virology 119:22-34 (i982).
Hirochika, H., Broker, T.R. & Chow, L.T., J. Virol. 61:2599-2606 (1987).
Herbomel et al., Cell 39:653 (1984).
Iyer, R. P., Phillips, L. R., Egan, W., Regan, J. and Beaucage, S. L., "The Automated Synthesis of Sulfur-Containing Oligodeoxyribonucleotides Using .sup.3 H-1,2-Bensodithiol-3-one 1,1-Dioxide as a Sulfur-Transfer Reagent", J. Org. Chem. 55:4693-4699 (1990).
Iversen, P. 1991, "In vivo studies with phosphorothioate oligonucleotides: pharmacokinetics prologue", Anticancer Drug Des. 6:531-538).
Kennedy et al., "A Negative Regulatory Element in the Human Papillomavirus Type 16 Genome Acts at the Level of Late mRNA Stability", J. Virol. 65, 2093-2097 (1991).
Lambert, P.F., Spalholz, B.A. & Howley, P.M., Cell 50:69-78 (1987).
Maniatis, T., Fritsch, E. F. and Sambrook, J. Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, New York, 1982.
McBride, A.A., Schlegel, R. & Howley, P.M., EMBO J. 7:533-539 (1988).
Moskaluk, C. & Bastia, D., Proc. Natl. Acad. Sci. USA 84:1215-1218 (1987).
Phelps, W.C. & Howley, P.M., J. Virol. 61:1630-1638 (1987).
Phelps, W. C. Yee, C. L., Munger, K., and Howley, P. M. 1988, "The Human Papillomavirus Type 16 E7 Gene Encodes Transactivation and Transformation Functions Similar to Those of Adenovirus E1A", Cell 53:539-547.
Rabson, M.S., Yee, C., Yang, Y.C. & Howley, P.M., J. Virol. 60:626-634 (1986).
Sambrook et al., Molecular Cloning. A Laboratory Manual, Cold Spring Harbor Laboratory Press, 1989, vol. 2, p. 10.59.
Sarver, N., Rabson, M.S., Yang, Y.C., Byrne, J.C. & Howley, P.M., J. Virol. 52:377-388 (1984).
Seedorf et al., "Human Papillomavirus Type 16 DNA Sequence", Virology 145, 181-185 (1985).
Spalholz, B.A., Yang, Y.C. & Howley, P.M., Cell 42:183-191 (1985).
Spalholtz et al., J. Virol. 61:2128-2137 (1987).
Spalholz, B. A., Byrne, J. C. and Howley, P. M., "Evidence for Cooperativity between E2 Binding Sites in E2 trans-regulation of Bovine Papillomavirus Type 1", J. Virol. 62:3143-3150 (1988).
Thierry, F. & Yaniv, M., EMBO J. 6:3391-3397 (1987).
Yang, Y.-C., Okayama, H. and Howley, P. M., "Bovine papillomavirus contains multiple transforming genes", Proc. Natl. Acad. Sci. USA 82:1030-1034 (1985).
Zur Hausen, H. and Schneider, A., The Papovaviridae, Eds. N.P. Salzman and P.M. Howley, Plenum Press, New York, 1987, vol. 2, pp. 245-264.
Cowsert Lex M.
Crooke Stanley T.
Ecker David J.
Mirabelli Christopher K.
ISIS Pharmaceuticals Inc.
Rees Dianne
Zitomer Stephanie W.
LandOfFree
Oligonucleotides for the diagnosis of papillomavirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oligonucleotides for the diagnosis of papillomavirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oligonucleotides for the diagnosis of papillomavirus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1958826